Mbfx V32

Mbfx

Description: In this great game Miniclip, you can play pool with players from around the world. Pool ball eight against live players. This is the complete experience online billiard ball 8. Winner-take-all. Control: With the mouse point to how easy and shoot the ball. Please check the corresponding box below if the form 8-store K it must be in the same time Thefiling the obligation of the Registrar under the following terms and conditions (see meet. General instruction. 2 below): the information contained in this current report on form 8-K, including annex AsExhibit 99 slides. is fully furnished 1 pursuant to this article 7 01 and not as forpurposes of section 18 of the Securities Exchange Act of 1934, modified (Stock Exchange Act) presented, Orotherwise fees in this section is not on any deposit of the Securities Act of 1933, as amended, or pursuant to the law of Exchange integrated Byreference keepeither before or after this date, unless express prior to deposit tienereferencia in this current report on form 8-k. Somaxon Noadmission simplifies the presentation of this report in the current form 8-K and furniture to this relationship of information to the materiality of the information contained in this report. The information contained in Theslides information, which are taken into account in the framework of the Somaxons Filingswith, the SEC and other public announcements are meant, the Somaxon which makes the release or again summarized in time. SOMAXON undertakes no duty or obligation to update publicly or to revise the Informationcontained in this report, although you can do as much as you think that Isappropriate management. This update may concerning the presentation of other reports or documents the SEC made releases of press or other public dissemination. This report is the registrant of Dulycaused under the rules of the Securities Exchange Act of 1934 on its behalf the undersigned to sign. StatementsThis presentation contains forward looking statements, I rejoice that Ourbusiness, including the results of our clinical trials of possible indications candidate intrinsic timeline products, upcoming events, financial development and that they have not materialized. Pharmaceutical Developmentinherently involves substantial risks and uncertainties, including the Risksoutlined under risk factors and elsewhere in our annual report OnForm 10-k and our other reports with the SEC from time to time. Our actual results may differ materially from our expectations Duet these risks and uncertainties, including: our dependence on the short time of our flagship product candidate success, SILENORTM, and the issuing of regulatory approvals, environmental industry in research and development, competition, intellectualproperty, Raisesufficient capital capacity, ability to attract strategic partners and Othermatters. SOMAXON is not necessary, revise or update the search Anyforward instructions, events, or circumstances after Ladata themselves. Pharmaceutical HighlightsSpecialty focus on psychiatric DisordersThree Andneurologic license candidates mbfx v32 experienced products, & RecordsHighly Extensivehuman distinguished security LargemarketsPositive product profiles-based phase 3 data addressing for unique drug forinsomnia1st not classified in the class for the control of drugs in pulse phase errors 2Company retains the exclusive rights to all the landmarks term ProductsNear including more phase 3 results. Pharmaceutical HighlightsSpecialty focus on psychiatric DisordersThree Andneurologic license candidates experienced products, & RecordsHighly Extensivehuman distinguished security LargemarketsPositive product profiles-based phase 3 data addressing for unique drug forinsomnia1st not classified in the class for the control of drugs in pulse phase errors 2Company retains the exclusive rights to all the landmarks term ProductsNear including more phase 3 results. . . . .